Clinical Trial Update: A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With High-Risk Early Breast Cancer [Phase 3]

View source ↗

Summary

A Phase III trial (NCT07349069) comparing HRS-8080 with standard endocrine therapy in high-risk early breast cancer is currently recruiting. No results are repo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HRS-8080
• Standard endocrine therapy

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING